Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
about
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and BackTargeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancerHigh-efficiency rare cell identification on a high-density self-assembled cell arrangement chip.Molecular pathways and targets in prostate cancerDo circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyBiodegradable nano-films for capture and non-invasive release of circulating tumor cells.Isolation and characterization of circulating tumor cells in prostate cancer.Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer.Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratificationCurrent management of prostate cancer: dilemmas and trialsBridging population and tissue scale tumor dynamics: a new paradigm for understanding differences in tumor growth and metastatic disease.The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.Enrichment, detection and clinical significance of circulating tumor cells.Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.Circulating tumor cells as promising novel biomarkers in solid cancers.Extracellular vesicles such as prostate cancer cell fragments as a fluid biopsy for prostate cancer.Pathologists and liquid biopsies: to be or not to be?Application of an improved magnetic immunosorbent in an Ephesia chip designed for circulating tumor cell capture.The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma.Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal TransitionNanoresonator chip-based RNA sensor strategy for detection of circulating tumor cells: response using PCA3 as a prostate cancer marker.
P2860
Q28068665-8073035E-A6D1-4861-BC2C-BBC78A20DB54Q28070333-33642E1A-6DB0-4AFD-B1D8-5D934FFC05ABQ33414863-629762B3-94D3-4437-9C23-314EB4872120Q33655571-22CC4769-8F76-4F33-A59B-38217BDE71FBQ34365632-F42EFC4F-F70A-4869-AD78-8A338F04B3C0Q35543094-7085B917-9666-4F99-8C06-F040A55D0CF7Q35682740-665C7A24-A761-446F-9CBA-73C3EEC2F9F4Q36310363-56A5E328-5533-451B-BDA0-8C5726A48E66Q36940245-5F8F8DA5-3B6F-4667-B874-12CF2F4AFADFQ37067529-0F01A2EB-CB2F-41C3-8B2C-4B26F6B29AA3Q37102535-AC259CE4-81A9-4892-BFE6-8FD0A6983B86Q37552264-07C0B8D2-BB1C-4359-B377-D4014780EFC4Q37992696-C32A74AC-E99F-4E8A-A30D-16EE0F59C279Q38102590-17EDAB0B-278B-45BD-9EFB-A7606811B55AQ38190483-AEF2E4B1-619F-49A6-BAF3-7060D9866FC7Q38196920-461B9AB2-DE57-4619-B4CD-5F4B44450F1FQ38474239-2ADF2251-BCED-4A42-8019-46F646FF4151Q38935060-BFAEFD06-A5DC-49AD-A676-51A09FDBAD1DQ39123704-86B5120D-AA40-46EE-A910-A056F97601D8Q40365240-D5A24BAB-A3E1-4ECB-925A-DAF0F87BC5E4Q41684073-9677112F-EFF3-46CE-8937-E2874E0C78B8Q41905663-A9621F06-974A-42D4-BAEE-95FE7934C8F2
P2860
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@en
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@nl
type
label
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@en
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@nl
prefLabel
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@en
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@nl
P2093
P1476
Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
@en
P2093
Emmanuel Chamorey
Hervé Naman
Jean-Michel Hannoun-Lévi
Jérôme Doyen
Scott K Parks
P304
P356
10.1016/J.CRITREVONC.2011.05.004
P577
2011-06-15T00:00:00Z